References
- Affara, N.I., Trempus, C.S., Schanbacher, B.L., Pei, P., Mallery, S.R., Bauer, J.A., and Robertson, F.M. (2006). Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multistage mouse skin carcinogenesis. Anticancer Res. 26, 2805-2820.
- Beck, B., Driessens, G., Goossens, S., Youssef, K.K., Kuchnio, A., Caauwe, A., Sotiropoulou, P.A., Loges, S., Lapouge, G., Candi, A., et al. (2011). A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478, 399-403. https://doi.org/10.1038/nature10525
- Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., and Corti, A. (2006). Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a oneyear proof-of-principle study. Cancer Res. 66, 1234-1240. https://doi.org/10.1158/0008-5472.CAN-05-1145
- Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. (2014). SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511, 246-250. https://doi.org/10.1038/nature13305
- Boutwell, R.K. (1977). The role of the induction of ornithine decarboxylase in tumor promotion. In Origins of Human Cancer, H.H. Hiatt, J. D. Watson and J. A. Winsten, eds. (New York, Cold Spring Harbor Laboratory), pp. 773-783.
- Conney, A.H., Wang, Z.Y., Huang, M.T., Ho, C.T., and Yang, C.S. (1992). Inhibitory effect of oral administration of green tea on tumorigenesis by ultraviolet light, 12-O-tetradecanoylphorobol-13-acetate and N-nitrosodiethylamine in mice. In Cancer Chemoprevention, L.W. Wattenberg, M. Lipkin, C.W. Boone, and G.J. Kelloff, eds. (Florida: CRC Press), pp. 361-373.
- Cross, S.E., Jin, Y.S., Rao, J.K., and Gimzewski, J.K. (2007). Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2, 780-783. https://doi.org/10.1038/nnano.2007.388
- Cross, S.E., Jin, Y.S., Lu, Q.Y., Rao, J.Y., and Gimzewski, J.K. (2011). Green tea extract selectively targets nanomechanics of liver metastatic cancer cells. Nanotechnology 22, 215101. https://doi.org/10.1088/0957-4484/22/21/215101
- Editor (1987). Green tea cuts cancerous growths. New Scientist. 116, 1586, 32.
- Fujiki, H. (2017). Green tea cancer prevention. In Encylopedia of Cancer, M. Schwab ed. (Berlin Heidelberg: Springer-Verlag), pp. 1960-1965.
- Fujiki, H., and Okuda T. (1992). (-)-Epigallocatechin gallate. Drugs Future 17, 462-464. https://doi.org/10.1358/dof.1992.017.06.175517
- Fujiki, H., and Suganuma, M. (1993). Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res. 61, 143-194.
- Fujiki, H., and Suganuma, M. (2002). Green tea and cancer prevention. Proc. Jpn. Acad. 78(B), 263-270. https://doi.org/10.2183/pjab.78.263
- Fujiki, H., Suganuma, M., Okabe, S., Sueoka, E., Sueoka, N., Fujimoto, N., Goto, Y., Matsuyama, S., Imai, K., and Nakachi, K. (2001). Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res. 480-481, 299-304. https://doi.org/10.1016/S0027-5107(01)00189-0
- Fujiki, H., Suganuma, M., Imai, K., and Nakachi, K. (2002). Green tea: cancer preventive beverage and/or drug. Cancer Lett. 188, 9-13. https://doi.org/10.1016/S0304-3835(02)00379-8
- Fujiki, H., Imai, K., Nakachi, K., Shimizu, M., Moriwaki, H., and Suganuma, M. (2012). Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J. Cancer Res. Clin. Oncol. 138, 1259-1270. https://doi.org/10.1007/s00432-012-1250-y
- Fujiki, H., Sueoka, E., and Suganuma, M. (2013). Tumor promoters: from chemicals to inflammatory proteins. J. Cancer Res. Clin. Oncol. 139, 1603-1614. https://doi.org/10.1007/s00432-013-1455-8
- Fujiki, H., Sueoka, E., Watanabe, T., and Suganuma, M. (2015a). Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds. J. Cancer Res. Clin. Oncol. 141, 1511-1522. https://doi.org/10.1007/s00432-014-1899-5
- Fujiki, H., Sueoka, E., Watanabe, T., and Suganuma, M. (2015b). Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J. Cancer Prev. 20, 1-4. https://doi.org/10.15430/JCP.2015.20.1.1
- Fujiki, H., Sueoka, E., Rawangkan, A., and Suganuma, M. (2017). Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. J. Cancer Res. Clin. Oncol. DOI: 10.1007/s00432-017-2515-2
- Fujita, Y., Yamane, T., Tanaka, M., Kuwata, K., Okuzumi, J., Takahashi, T., Fujiki, H., and Okuda, Y. (1989). Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N'-nitro-Nnitrosoguanidine in mouse duodenum. Jpn. J. Cancer Res. 80, 503-505. https://doi.org/10.1111/j.1349-7006.1989.tb01666.x
- Gerdes, M.J., and Yuspa, S.H. (2005). The contribution of epidermal stem cells to skin cancer. Stem Cell Rev. 1, 225-231. https://doi.org/10.1385/SCR:1:3:225
- Gupta, S., Hastak, K., Ahmad, N., Lewin, J.S., and Mukhtar, H. (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 98, 10350-10355. https://doi.org/10.1073/pnas.171326098
- Hoensch, H., Groh, B., Edler, L., and Kirch, W. (2008). Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J. Gastroenterol. 14, 2187-2193. https://doi.org/10.3748/wjg.14.2187
- Imai, K., Suga, K., and Nakachi, K. (1997). Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26, 769-775. https://doi.org/10.1006/pmed.1997.0242
- Inoue, M., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Hirose, K., Hamajima, N., and Tominaga, S. (2001). Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiological Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 167, 175-182. https://doi.org/10.1016/S0304-3835(01)00486-4
- Jones, P.H., and Watt, F.M. (1993). Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73, 713-724. https://doi.org/10.1016/0092-8674(93)90251-K
- Kashyap, V., Rezende, N.C., Scotland, K.B., Shaffer, S.M., Persson, J.L., Gudas, L.J., and Mongan, N.P. (2009). Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 18, 1093-1108. https://doi.org/10.1089/scd.2009.0113
- Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S.J., and Fujiki, H. (1993). Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 23, 186-190
- Lin, C.H., Shen, Y.A., Hung, P.H., Yu, Y.B., and Chen, Y.J. (2012). Epigallocatechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines. BMC Complement Alern. Med. 12, 201. https://doi.org/10.1186/1472-6882-12-S1-P201
- Mineva, N.D., Paulson, K.E., Naber, S.P., Yee, A.S., and Sonenshein, G.E. (2013). Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells. PLoS One 8, e73464. https://doi.org/10.1371/journal.pone.0073464
- Morris, R.J., Tryson, K.A., and Wu, K.Q. (2000). Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis or infundibulum as well as in the hair follicles. Cancer Res. 60, 226-229.
- Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., and Higashi, Y. (1998). Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89, 254-261. https://doi.org/10.1111/j.1349-7006.1998.tb00556.x
- Nakachi, K., Matsuyama, S., Miyake, S., Suganuma, M., and Imai, K. (2000). Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactor 13, 49-54. https://doi.org/10.1002/biof.5520130109
- Ogunleye, A.A., Xue, F., and Michels, K.B. (2010). Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 119, 477-484. https://doi.org/10.1007/s10549-009-0415-0
- Okabe, S., Suganuma, M., Hayashi, M., Sueoka, E., Komori, A., and Fujiki, H. (1997). Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res. 88, 639-643. https://doi.org/10.1111/j.1349-7006.1997.tb00431.x
- Okabe, S., Ochiai, Y., Aida, M., Park, K., Kim, S.J., Nomura, T., Suganuma, M., and Fujiki, H. (1999). Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn. J. Cancer Res. 90, 733-739. https://doi.org/10.1111/j.1349-7006.1999.tb00808.x
-
Pan, X., Zhao, B., Song, Z., Han, S., and Wang, M. (2016). Estrogen receptor-
${\alpha}$ 36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells. J. Pharmacol. Sci. 130, 85-93. https://doi.org/10.1016/j.jphs.2015.12.003 - Sarkar, A., and Hochedlinger K (2013). The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 12, 15-30. https://doi.org/10.1016/j.stem.2012.12.007
- Shimizu, M., Fukutomi, Y., Ninomiya, M., Nagura, K., Kato, T., Araki, H., Suganuma, M., Fujiki, H., and Moriwaki, H. (2008). Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 17, 3020-3025. https://doi.org/10.1158/1055-9965.EPI-08-0528
- Shin, C.M., Lee, D.H., Seo, A.Y., Lee, H.J., Kim, S.B., Son, W.C., Kim, Y.K., Lee, S.j., Park, S.H., Kim, N., et al. (2017). Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial. Clin. Nutr. Pii:S0261-5614(17)30038-9.
- Slaga, T.J., and Klein-Szanto, A.J. (1983). Initiation-promotion versus complete skin carcinogenesis in mice: importance of dark basal keratinocytes (stem cells). Cancer Invest. 1, 425-436. https://doi.org/10.3109/07357908309048511
- Sporn, M.B., Dunlop, N.M., Newton, D.L., and Smith, J.M. (1976). Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 35, 1332-1338.
- Stearns, M.E., and Wang, M. (2011). Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl. Oncol. 4, 147-156. https://doi.org/10.1593/tlo.10286
- Stingl, J.C., Ettrich, T., Muche, R., Wiedom, M., Brockmoller, J., Seeginger, A., and Seufferlein, T. (2011). Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. B.M.C. Cancer 11, 360. https://doi.org/10.1186/1471-2407-11-360
- Suganuma, M., Fujiki, H., Suguri, H., Yoshizawa, S., Hirota, M., Nakayasu, M, Ojika, M., Wakamatsu, K., Yamada, K., and Sugimura, T. (1988). Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA 85, 1768-1771. https://doi.org/10.1073/pnas.85.6.1768
-
Suganuma, M., Okabe, S., Oniyama, M., Tada, Y., Ito, H., and Fujiki, H. (1998). Wide distribution of [
$^{3}H$ ](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19,1771-1776. https://doi.org/10.1093/carcin/19.10.1771 - Suganuma, M., Okabe, S., Kai, Y., Sueoka, N., Sueoka, E., and Fujiki, H. (1999). Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 59, 44-47.
- Suganuma, M., Kurusu, M., Suzuki, K., Tasaki, E., and Fujiki, H. (2006). Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int. J. Cancer 119, 33-40. https://doi.org/10.1002/ijc.21809
- Suganuma, M., Saha, A., and Fujiki, H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci. 102, 317-323. https://doi.org/10.1111/j.1349-7006.2010.01805.x
- Suganuma, M., Takahashi, A., Watanabe, T., Iida, K., Matsuzaki, T., Yoshikawa, H.Y., and Fujiki, H. (2016). Biophysical approach to mechanisms of cancer prevention and treatment with green tea catechins. Molecules 21, pii: E1566.
- Surh, Y.J. (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768-780. https://doi.org/10.1038/nrc1189
- Takahashi, A., Watanabe, T., Mondal, A., Suzuki, K., Kurusu-Kanno, M., Li, Z., Yamazaki, T., Fujiki, H., and Suganuma, M. (2014). Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate. Biochem. Biophys. Res. Commun. 443, 1-6. https://doi.org/10.1016/j.bbrc.2013.10.094
- Tang, S.N., Fu, J., Nall, D., Rodova, M., Shankar, S., and Srivastava, R.K. (2012). Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int. J. Cancer 131, 30-40. https://doi.org/10.1002/ijc.26323
- Taniguchi, S., Fujiki, H., Kobayashi, H., Go, H., Miyado, K., Sadano, H., Shimokawa, R. (1992). Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett. 65, 51-54. https://doi.org/10.1016/0304-3835(92)90212-E
- Toden, S., Tran, H.M., Tovar-Camargo, O.A., Okugawa, Y., and Goel, A. (2016). Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Oncotarget. 7, 16158-16170.
- Trempus, C.S., Morris, R.J., Ehinger, M., Elmore, A., Bortner, C.D., Ito, M., Cotsarelis, G., Nijhof, J.G.W., Peckham, J., Flagler, N., et al. (2007). CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res. 67, 4173-4181. https://doi.org/10.1158/0008-5472.CAN-06-3128
- Tsao, A.S., Liu, D., Martin, J., Tang, X.M., Lee, J.J., El-Naggar, A.K., Wistuba, I., Culotta, K.S., Mao, L., Gillenwater, A., et al. (2009). Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev. Res. 2, 931-941. https://doi.org/10.1158/1940-6207.CAPR-09-0121
- Watanabe, T., Kuramochi, H., Takahashi, A., Imai, K., Katsuta, N., Nakayama, T., Fujiki, H., and Suganuma, M. (2012). Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells. J. Cancer Res. Clin. Oncol. 138, 859-866. https://doi.org/10.1007/s00432-012-1159-5
- Yamane, T., Takahashi, T., Kuwata, K., Oya, K., Inagake, M, Kitao, Y., Suganuma, M, and Fujiki, H. (1995). Inhibition of N-methyl-N’-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55, 2081-2084.
- Yang, C.S., Wang, X., Lu, G., and Picinich, S.C. (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 9, 429-439. https://doi.org/10.1038/nrc2641
- Yoshizawa, S., Horiuchi, T., Fujiki, H., Yoshida, T., Okuda, T., and Sugimura, T. (1987). Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea. Phytother. Res. 1, 44-47. https://doi.org/10.1002/ptr.2650010110
-
Yoshizawa, S., Horiuchi, T., Suganuma, M., Nishiwaki, S., Yatsunami, J., Okabe, S., Okuda, T., Muto, Y., Frenkel, K., Troll, W., et al. (1992). Penta-O-galloyl-
${\beta}$ -D-glucose and (-)-epigallocatechin gallate cancer preventive agents. ACS Symposium Series. 501, 316-325. -
Zhang, X.T., Kang, L.G., Ding, L., Vranic, S., Gatalica, Z., and Wang, Z.T. (2011). A positive feedback loop of ER-
${\alpha}$ 36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 30, 770-780. https://doi.org/10.1038/onc.2010.458 -
Zhu, J., Jiang, Y., Yang, X., Wang, S., Xie, C., Li ,X., Li, Y., Chen, Y., Wang, X., Meng, Y., et al. (2017). Wnt/
${\beta}$ -catenin pathway mediates (-)-epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells. Biochemical Biophys. Res. Commun. 482, 15-21. https://doi.org/10.1016/j.bbrc.2016.11.038
Cited by
- Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth vol.23, pp.8, 2018, https://doi.org/10.3390/molecules23082071
- Prevention of breast cancer by dietary polyphenols—role of cancer stem cells pp.1549-7852, 2019, https://doi.org/10.1080/10408398.2018.1551778
- Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects vol.37, pp.1, 2018, https://doi.org/10.1186/s13046-018-0929-6
- Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth vol.8, pp.None, 2018, https://doi.org/10.3389/fonc.2018.00356
- Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer vol.5, pp.3, 2018, https://doi.org/10.3390/medicines5030087
- Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics vol.61, pp.22, 2018, https://doi.org/10.1021/acs.jmedchem.8b00185
- Green Tea Consumption and Risk of Breast Cancer and Recurrence—A Systematic Review and Meta-Analysis of Observational Studies vol.10, pp.12, 2018, https://doi.org/10.3390/nu10121886
- Regulation of Neprilysin Activity and Cognitive Functions in Rats After Prenatal Hypoxia vol.44, pp.6, 2018, https://doi.org/10.1007/s11064-019-02796-3
- Multilevel structure-activity profiling reveals multiple green tea compound families that each modulate ubiquitin-activating enzyme and ubiquitination by a distinct mechanism vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-48888-6
- Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer vol.24, pp.5, 2018, https://doi.org/10.3390/molecules24050954
- Prevention of therapy-related malignances in cancer survivors vol.10, pp.22, 2018, https://doi.org/10.18632/oncotarget.26781
- Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors vol.24, pp.9, 2018, https://doi.org/10.3390/molecules24091726
- A review of nutrition and dietary interventions in oncology vol.8, pp.None, 2018, https://doi.org/10.1177/2050312120926877
- The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/9181549
- Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action vol.11, pp.None, 2018, https://doi.org/10.3389/fimmu.2020.580208
- Recent advances in natural therapeutic approaches for the treatment of cancer vol.32, pp.2, 2018, https://doi.org/10.1080/1120009x.2019.1707417
- Antimetastatic Properties of Tea Polyphenols vol.72, pp.3, 2018, https://doi.org/10.1080/01635581.2019.1638426
- Coumaroyl Flavonol Glycosides and More in Marketed Green Teas: An Intrinsic Value beyond Much-Lauded Catechins vol.25, pp.8, 2018, https://doi.org/10.3390/molecules25081765
- Nutrigenomics: Epigenetics and cancer prevention: A comprehensive review vol.60, pp.8, 2020, https://doi.org/10.1080/10408398.2019.1571480
- Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers vol.9, pp.5, 2018, https://doi.org/10.3390/antiox9050440
- Effects and mechanisms of tea for the prevention and management of cancers: An updated review vol.60, pp.10, 2020, https://doi.org/10.1080/10408398.2019.1588223
- Effective disposal of methylene blue using green immobilized silver nanoparticles on graphene oxide and reduced graphene oxide sheets through one-pot synthesis vol.192, pp.6, 2020, https://doi.org/10.1007/s10661-020-08278-2
- MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors vol.12, pp.8, 2018, https://doi.org/10.3390/cancers12082111
- An Update on the Role of Dietary Phytochemicals in Human Skin Cancer: New Insights into Molecular Mechanisms vol.9, pp.10, 2018, https://doi.org/10.3390/antiox9100916
- Effectiveness of concomitant use of green tea and polyethylene glycol in bowel preparation for colonoscopy: a randomized controlled study vol.20, pp.None, 2020, https://doi.org/10.1186/s12876-020-01220-3
- Camellia Sinensis Mouthwashes in Oral Care: a Systematic Review vol.21, pp.4, 2020, https://doi.org/10.30476/dentjods.2020.83204.1045
- Health Benefits and Chemical Composition of Matcha Green Tea: A Review vol.26, pp.1, 2018, https://doi.org/10.3390/molecules26010085
- Epigallocatechin-3-gallate Can Prevent Type 2 Human Papillomavirus E7 from Suppressing Interferon-Stimulated Genes vol.22, pp.5, 2018, https://doi.org/10.3390/ijms22052418
- EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells vol.25, pp.16, 2018, https://doi.org/10.1111/jcmm.16718
- Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer vol.22, pp.18, 2018, https://doi.org/10.3390/ijms22189807